Evidence map›Paper›PMID 39505345›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[Quercetin ameliorates diabetic kidney injury in rats by inhibiting the HMGB1/RAGE/NF-κB signaling pathway].

Y Jiang, X Li, J Geng, Y Chen, B Tang, P Kang

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Y JiangSchool of Clinical Medicine, Bengbu Medical University, Bengbu 233000, China.
X LiDepartment of Cardiovascular Medicine of First Affiliated Hospital, Bengbu Medical University, Bengbu 233000, China.
J GengSchool of Psychiatric Medicine, School of Mental Health, Bengbu Medical University, Bengbu 233000, China.
Y ChenDepartment of Cardiovascular Medicine of First Affiliated Hospital, Bengbu Medical University, Bengbu 233000, China.
B TangDepartment of Cardiovascular Medicine of First Affiliated Hospital, Bengbu Medical University, Bengbu 233000, China.
P KangDepartment of Cardiovascular Medicine of First Affiliated Hospital, Bengbu Medical University, Bengbu 233000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the effect of quercetin on renal inflammation and cell apoptosis in diabetic rats and its possible mechanisms.

methodsTwenty-four adult male SD rats were randomized equally into normal control group, high-glucose and high-fat feeding group, streptozotocin (STZ) -induced diabetic model group, and quercetin treatment (daily dose 100 mg/kg) group. Pathological changes of the renal tissues of the rats were observed with HE staining, serum inflammatory factor levels were determined with ELISA, and renal expression of NF‑κB was observed by immunohistochemistry. Fast blood glucose (FBG), serum levels of triglyceride (TG), BUN, and Scr, and 24-h urine protein content of the rats were measured, and renal expressions of HMGB1, RAGE, NF‑κB, Bax, Bcl-2, and caspase-3 were detected with Western blotting.

resultsThe diabetic rats showed significantly increased levels of FBG, TG, BUN, and Scr, renal hypertrophy index, 24-h urinary protein content, serum IL-1β, IL-6 and TNF-α levels and renal expressions HMGB1, RAGE, NF‑κB, Bax, and caspase-3 with decreased renal expression of Bcl-2. All these changes were significantly alleviated by quercetin treatment of the rats.

conclusionQuercetin can ameliorate kidney injury in diabetic rats possibly by inhibiting the HMGB1/RAGE/NF-κB inflammatory signaling pathway to reduce renal inflammation and renal cell apoptosis.

Indexed as

ApoptosisDiabetes Mellitus, ExperimentalDiabetic NephropathiesHMGB1 ProteinKidneyNF-kappa BQuercetinRats, Sprague-DawleySignal TransductionAnimalsCaspase 3Interleukin-1betaInterleukin-6MaleRatsReceptor for Advanced Glycation End ProductsCaspase 3Hbp1 protein, ratHMGB1 ProteinInterleukin-1betaInterleukin-6NF-kappa BQuercetinReceptor for Advanced Glycation End ProductsTumor Necrosis Factor-alphadiabetic nephropathyHMGB1/ RAGE/ NF-κB signaling pathwayquercetin

Identifiers

PMID39505345
PMCPMC11744097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.